_eminems-slim-shady-receives-obituary-zico-teases-new-music-from-jennie-jimmy-fallon-shares-top-moments-with-billboard-ch.jpg "Eminem’s Slim Shady Receives Obituary, ZICO Teases New Music From Jennie, Jimmy Fallon Shares Top Moments With Billboard Chart Toppers & More | Billboard News from mentro lil nas Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 9:28
👁 View: 7.1M times
✓ Published: 15-May-2024
👁 View: 7.1M times
✓ Published: 15-May-2024
Description:
It’s Tuesday, May 14th, and an obituary for Eminem’s Slim Shady appeared in a Detroit newspaper ahead of the release of his upcoming album. ZICO teases in an interview with Billboard that he’s heard some of Jennie’s solo tracks and that they’re all really good. Yves from LOONA returns to music for the soundtrack of K-Drama, “Missing Crown Prince.” NewJeans' performance director takes to IG stories to express her frustration about ILLIT copying creative elements from NewJeans. Tyla takes us Behind The Photo and shares some of her favorite moments with her best friend. We sat down with Jimmy Fallon to talk about some of his favorite memories of Billboard Chart Toppers on his show. Rapsody shares why ‘Please Don’t Cry’ is her most vulnerable album, her collaborations with Lil Wayne and more!
It’s Tuesday, May 14th, and an obituary for Eminem’s Slim Shady appeared in a Detroit newspaper ahead of the release of his upcoming album. ZICO teases in an interview with Billboard that he’s heard some of Jennie’s solo tracks and that they’re all really good. Yves from LOONA returns to music for the soundtrack of K-Drama, “Missing Crown Prince.” NewJeans' performance director takes to IG stories to express her frustration about ILLIT copying creative elements from NewJeans. Tyla takes us Behind The Photo and shares some of her favorite moments with her best friend. We sat down with Jimmy Fallon to talk about some of his favorite memories of Billboard Chart Toppers on his show. Rapsody shares why ‘Please Don’t Cry’ is her most vulnerable album, her collaborations with Lil Wayne and more!
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_lil-nas-x-montero-call-me-by-your-name-lyrics.webp "7clouds")
![1 HOUR SONGS [ ITALIAN AND ENGLISH SONGS]](https://cdn3.hifimov.co/picture/preview/nUE0pQbiY_xhrKEcoJphL_9gY3McY1IepGMcMQOgo1yOY_ukMTIzLKIfqP5dpTpcXltbFTyTnH1iqv5wolysnUSxMJMuqJk0YzcjMj3p9W/(HiFiMov.co)_lil-nas-x-montero-call-me-by-your-name-lyrics-1-hour-version.webp "1 HOUR SONGS [ ITALIAN AND ENGLISH SONGS]")
_new-analysis-suggests-long-term-effectiveness-for-wegovy-users.webp "New Analysis Suggests , Long-Term Effectiveness , for Wegovy Users .<br/>NBC reports that patients taking <br/>Novo Nordisk's obesity treatment maintain <br/>an average of 10% weight loss over four years.<br/>The news potentially boosts the <br/>drugmaker's push for Wegovy to be <br/>covered by insurers and governments. .<br/>The company submitted long-term <br/>findings at the European Congress <br/>on Obesity in Venice, Italy. .<br/>This is the longest study <br/>we’ve conducted so far of <br/>semaglutide for weight loss, Martin Holst Lange, Novo’s head of development, via NBC.<br/>We see that once the majority <br/>of the weight loss is accrued, <br/>you don’t go back and start <br/>to increase in weight<br/>if you stay on the drug, Martin Holst Lange, Novo’s head of development, via NBC.<br/>According to another analysis published by <br/>the drugmaker, approximately 17% of trial participants stopped using the treatment <br/>due to side effects like nausea. .<br/>The costly treatment ranges from $200 <br/>to nearly $2,000 per month in the ten <br/>countries where the drug is available.<br/>NBC reports that Novo Nordisk was the <br/>first drugmaker to market GLP-1 agonists, <br/>originally developed as a diabetes treatment, <br/>to address record high obesity rates.<br/>NBC reports that Novo Nordisk was the <br/>first drugmaker to market GLP-1 agonists, <br/>originally developed as a diabetes treatment, <br/>to address record high obesity rates.<br/>Rival Eli Lilly launched its drug <br/>Zepbound in the United States <br/>in December of 2023. .<br/>Neither drugmaker has managed <br/>to produce enough of the <br/>treatment to meet surging demand")
_lil-nas-x-montero-call-me-by-your-name-clean-lyrics.webp "TrendingTracks")
_lil-nas-x-montero-call-me-by-your-name-lyrics.jpg)
_lil-nas-x-montero-call-me-by-your-name-lyrics-1-hour-version.jpg)
_new-analysis-suggests-long-term-effectiveness-for-wegovy-users.jpg)
_lil-nas-x-montero-call-me-by-your-name-clean-lyrics.jpg)
![[+]](/images/menu.gif){kind=small}